cytarabine and Breast Cancer

cytarabine has been researched along with Breast Cancer in 132 studies

Research

Studies (132)

TimeframeStudies, this research(%)All Research%
pre-199037 (28.03)18.7374
1990's26 (19.70)18.2507
2000's34 (25.76)29.6817
2010's27 (20.45)24.3611
2020's8 (6.06)2.80

Authors

AuthorsStudies
Celewicz, L; Czarnecka, A; Hoffmann, M; Hładoń, B; Jóźwiak, A; Laskowska, H; Olejnik, A; Ruszkowski, P1
Bhaskaran Sathyabhama, A; Geethakumari, D; Mohandas, D; Raji Sathyan, K; Somasekharan, JV; Thavarool Puthiyedathu, S1
Gu, L; Liu, L; Luo, YH; Wu, HY1
Barrière, J; Bonneterre, J; Boulanger, T; Le Deley, MC; Le Rhun, E; Lorgis, V; Mailliez, A; Robin, YM; Rodrigues, I; Wallet, J; Weller, M1
Islam, S; Pal, S; Santra, MK; Sivakrishna, B1
Lee, EQ1
Andrews, C; Maze, D; Murphy, T; Sibai, H1
Dorn, J; Drecoll, E; Frejno, M; Heinzlmeir, S; Helm, D; Hogrebe, A; Kleigrewe, K; Kuster, B; Kvasnicka, HM; Meng, C; Mergner, J; Oellerich, T; Ruprecht, B; Samaras, P; Scheich, S; Serve, H; Weichert, W; Wilhelm, M; Zecha, J1
Gogia, B; Rai, P; Shivaprasad, A; Tremont-Lukats, IW1
Le Deley, MC; Le Rhun, E; Weller, M1
Agostoni, V; Couvreur, P; Gref, R; Lampropoulou, M; Lazarou, YG; Maksimenko, A; Rodriguez-Ruiz, V; Salzano, G; Yannakopoulou, K1
Guillaume, C; Lanotte, P; Le Brun, C; Pastuszka, A; Vegas, H1
Graham, C; Gralow, J; Johnson, N; Kim, B; Kurland, BF; Mrugala, MM; Sharma, A1
Akahane, D; Azuma, K; Katagiri, S; Ohyashiki, K; Saito, K1
André, C; Assaker, R; Baranzelli, MC; Bonneterre, J; Boulanger, T; Cazin, JL; Chamberlain, MC; Devos, P; Dubois, F; Kotecki, N; Le Rhun, E; Mailliez, A; Marliot, G; Servent, V; Taillibert, S; Vanlemmens, L; Vennin, P; Zairi, F1
Aittomäki, K; Blomqvist, C; Carpén, O; Fagerholm, R; Heikkilä, P; Heikkinen, T; Khan, S; Korpela, T; Nevanlinna, H1
Cui, J; Guo, R; Hoffman, AR; Hu, JF; Li, W; Sun, J; Wang, G; Wang, H1
Chan, HN; Ha, CY; Lai, HK; Law, MF; Leung, C; Ng, C; Yeung, YM; Yip, SF1
Bazhenova, L; Brown, BD; Brown, T; Carter, BS; Chen, CC; Fanta, P; Helsten, T; Kesari, S; Parker, B; Piccioni, DE; Pingle, S; Rush, T; Saria, MG; Schwab, R; Scott, BJ; van Vugt, VA1
Park, KY; Qiu, P1
Murawska, M; Niwińska, A; Rudnicka, H1
Jamaluddin, MA; Nalwa, A; Nath, D; Srivastava, A; Suri, V1
Aboukais, R; Assaker, R; Bertrand, N; Boulanger, T; Chamberlain, MC; Le Rhun, E; Taillibert, S; Zairi, F1
Ji, H; Liu, T; Nanding, A; Xuan, Q; Yan, C; Zhang, Q1
Amin, K; Barbarotta, L; Gore, SD; Kasberg, S; Kim, TK; Podoltsev, NA; Prebet, T; Roche, K; Stahl, M; Xu, ML; Zeidan, AM1
Anzalone, AA; Cajozzo, M; Fatica, F; Geraci, G; Modica, G1
Glas, M; Herrlinger, U; Rasch, K; Stuplich, M; Tschampa, H; Urbach, H1
Galmarini, CM; Kohli, E; Mitin, A; Vinogradov, SV; Warren, G; Zeman, A1
Enomoto, T; Hayashi, K; Iizuka, M; Kuranami, M; Nakakuma, T; Sengoku, N; Watanabe, M; Yoshimura, N1
Corsini, E; Erbetta, A; Gaviani, P; Salmaggi, A; Silvani, A1
Pan, IW; Shih, YC; Tsai, YW1
Chao, TY; Huang, TC1
Buhk, JH; Hoffmann, AL; Strik, H1
Atkins, CD2
Amano, S; Enomoto, K; Sakurai, K1
Hu, W; Li, L; Sheng, Y; Shi, J; Su, D; Wang, CK1
Liskova, S; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Porsok, S; Rajec, J; Sycova-Mila, Z1
Adrada, BE; Carkaci, S; Whitman, GJ1
Chen, S; Fu, R; Gu, H; Li, Q; Wang, Y; Wu, H; Yuan, K; Zhang, K; Zhang, L1
Kucerova, L; Matuskova, M; Poturnajova, M; Tyciakova, S1
Bernard, PS; Cheang, MC; Chia, SK; Davies, S; Davis, C; Ebbert, MT; Ellis, MJ; Jiang, S; Leung, S; Levine, MN; Nielsen, TO; Parker, JS; Perou, CM; Pritchard, KI; Shepherd, LE; Stijleman, IJ; Tu, D; Voduc, KD1
Aiken, R; Baidas, S; Batchelor, T; Cohn, A; Fulton, D; Gilbert, M; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; Kennedy, JM; Lesser, G; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Rogers, L; Russell, C; Swinnen, LJ; Wong, E1
Hada, M; Koshizuka, K; Muto, S; Nakagomi, H; Takano, K1
Bramwell, V; Crump, M; Levine, M; Pritchard, K; Shepherd, L; Tu, D1
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR1
Chajek-Shaul, T; Cukierman, T; Ilsar, M; Liebster, D; Planer, D1
Deckert, M; Montesinos-Rongen, M; Pels, H; Schaller, C; Schlegel, U; Van Roost, D; Wiestler, OD1
Bjornsti, MA; de Jong, LA; Jansen, LE; Pluim, D; Schellens, JH; van Eijndhoven, MA; van Waardenburg, RC; Verseyden, C1
Ikeda, K; Matsumoto, K; Matsuoka, S; Ohta, M; Takeshita, I1
Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T1
Bell, C; Bighin, C; Boni, L; Catzeddu, T; Clavarezza, M; Del Mastro, L; Sertoli, MR; Testa, D; Venturini, M1
Ambrózay, E; Boross, G; Gyánti, R; Hajnal, L; Lorincz, M; Maráz, R; Markó, L; Svébis, M; Szucs, M; Vizhányó, R1
Jida, M; Kubo, M; Maeda, H; Miyatani, K; Mizuta, M; Shirakawa, K; Sogabe, O; Udaka, T; Yamane, M1
Bader, Y; Fritzer-Szekeres, M; Grusch, M; Hartmann, J; Krupitza, G; Leisser, C; Mader, RM; Madlener, S; Maier, S; Saiko, P; Sasgary, S; Schott, H; Strasser, S; Szekeres, T1
Bader, Y; Bernhaus, A; Fritzer-Szekeres, M; Gueorguieva, M; Krupitza, G; Leisser, C; Mader, RM; Madlener, S; Maier, S; Richter, S; Saiko, P; Schott, H; Strasser, S; Szekeres, T; Wesierska-Gadek, J1
Jensen, AB; Johansson, A; Mehlsen, M; Paulsen, K; von der Maase, H; Zachariae, R1
Andersen, J; Bergh, J; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, BB; Jensen, MB; Kamby, C; Mouridsen, HT; Nordenskjold, B1
Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z1
Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D1
Ayus, C; Cook, G; Daskal, Y; Espada, R; Feldman, L; Frommer, P; Henry, JF; Howell, JF; Lehane, D; Mattioli, C; Miller, L; Shearer, WT; Terman, DS; Tillquist, R; Yamamoto, T; Young, JB; Zaleski, HI1
Carpenter, J; Fishkin, E; Krauss, S; Moore, MR; Raab, S; Raney, M; Smalley, RV; Stagg, M; Velez-Garcia, E; Vogel, CL1
Baguley, BC; Finlay, GJ1
Bartolucci, AA; Carpenter, J; Lefante, J; Marcial, V; Moore, M; Perez, CA; Smalley, RV; Velez-Garcia, E; Vogel, C; Wittliff, J1
Csoka, K; Larsson, R; Liliemark, J; Nygren, P1
Gurtler, J; Liebmann, J1
Amadori, D; Baldini, E; Brema, F; Gardin, G; Monzeglio, C; Naso, C; Pastorino, G; Pronzato, P; Rosso, R; Rubagotti, A1
Hapke, DM; Mitchell, BS; Stegmann, AP1
Bohr, VA; Cowans, KH; Parshad, R; Price, FM; Sanford, KK; Zujewski, JA1
Andreotti, PE; Bruckner, HW; Cree, IA; Dewar, JA; Hunter, EM; James, EA; Kurbacher, CM; Preece, PE; Subedi, AM; Sutherland, LA; Untch, M1
Boder, GB; Grindey, GB; Hertel, LW; Houghton, JA; Houghton, PJ; Merriman, RL; Rutherford, PG; Schultz, RM; Tanzer, LR1
Christensen, C; Deppe, G; Lawrence, WD; Ruan, H; Saunders, DE; Wappler, NL1
Chen, WD; Coxon, AB; Kaye, FJ; Khleif, SN; Lipkowitz, S; Otterson, GA1
Forman, SJ; Margolin, KA; Wright, C1
Czaykowski, PM; Oza, A; Samuels, T1
Berdel, WE; Bergmann, J; Brachwitz, H; Fichtner, I; Langen, P; Thomas, Y; Vollgraf, C1
Cole, KJ; Grover, PL; Martin, FL; Phillips, DH; Weaver, G1
Hanaoka, K; Hisaoka, M; Ikeda, T; Iwabuchi, H; Kaneko, M; Kobayashi, T; Kurakata, S; Matsuda, A; Mitsuhashi, Y; Miura, S; Nakagawa, A; Nomura, T; Sasaki, T; Shibayama, T; Suzuki, M; Tanaka, K; Tanzawa, F; Tomida, A; Tsuruo, T; Wataya, Y1
Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S1
Ennis, M; Goodwin, PJ; Hood, N; Pritchard, KI; Trudeau, M1
Chamberlain, MC; Cole, BF; Glantz, MJ; Howell, SB; Jaeckle, KA; LaFollette, S; Maria, B; Phuphanich, S; Recht, L; Schumann, GB; Swinnen, LJ1
Alvarez, E; Buesa, JM; Corral, N; Estaban, E; Estrada, E; Fernández, JL; Lacave, AJ; Muñiz, I; Palacio, I; Vieitez, JM1
Abdel-Aziz, W; Hickey, RJ; Jiang, HY; Malkas, LH2
Clowes, C; Duarte, R; Pu, QQ; Wang, X2
Björkholm, M; Gruber, A; Hansson, M; Steingrimsdottir, H; Svensson, A1
Chen, HC; Fang, FM; Hsiung, CY; Hsu, HC; Huang, EY; Sun, LM; Wang, CJ; Wu, JM; Yeh, SA1
Esteva, FJ; Forman, AD; Holmes, FA; Hortobagyi, GN; Meyers, CA; Plunkett, W; Soh, LT1
Aiken, R; Akerley, W; Allen, J; Baidas, S; Batchelor, T; Bent, MJ; Campbell, T; Chamberlain, MC; Cohn, A; Fulton, D; Gertler, SZ; Gilbert, M; Glantz, MJ; Greenberg, HS; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; LaFollette, S; Lesser, G; Maria, B; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Recht, L; Rogers, L; Russell, C; Shapiro, W; Swinnen, L; Wong, E1
Ackland, SP; Anton, A; Breitbach, GP; Colajori, E; Delfino, C; Efremidis, A; Ezzat, A; Fittipaldo, A; Kolaric, K; Lopez, M; Tursi, JM; Viaro, D1
Canavese, G; Cavallari, M; Del Mastro, L; Guenzi, M; Ricci, P; Sanguineti, G; Stevani, I; Venturini, M1
Baba, K; Fukuda, M; Matsuda, M; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Yamashita, H1
Durodola, JI1
Alberto, P; Brugarolas, A; Cavalli, F; Gangji, D; Hansen, HH; Rozencweig, M; Siegenthaler, P; Sylvester, R1
Baker, L; Hoogstraten, B; O'Bryan, RM; Salmon, S; Vaughn, C; Whitecar, J1
Schabel, FM1
Calabresi, P; Cummings, FJ; Hoovis, ML1
Cantillo, R; Jain, J; Singhakowinta, A; Vaitkevicius, VK1
Kondo, H; Nomura, Y; Yamagata, J1
Hellman, S; Little, JB; Nove, J; Piro, AJ; Weichselbaum, RR1
Hellman, S; Little, JB; Nove, JJ; Piro, AJ; Weichselbaum, RR1
Nakamura, M; Yamaguchi, T1
DePhilip, RM; Lieberman, I; Lynch, WE1
Broder, LE; Carbone, PP1
Bashir, RM; Foley, J; Gasecki, AP1
Hori, T; Kan, N; Kato, H; Kodama, H; Kudo, N; Mukaihara, S; Ogawa, H; Ohsumi, K; Takenaka, A; Yasumura, T1
Cersosimo, RJ1
Faraggi, D; Henderson, IC; Kalra, J; Korzun, AH; Moore, A; Oster, MW; Perry, M; Schilsky, RL; Wood, WC1
Carpen, M; Cohen, JS; Daly, PF; Myers, CE; Sandler, D; Zugmaier, G1
Boogerd, W; Moffie, D; Smets, LA1
Abe, M; Kufe, D1
Büchner, T; Essink, M; Hiddemann, W; Huhn, D; Jung, M; Koppensteiner, R; Marosi, L; Martin, T; Minar, E; Siegert, W1
Ota, K1
Giannone, L; Greco, FA; Hainsworth, JD1
Bourguignat, A; Eydoux, P; Floiras, JL; Le Doussal, V; Trassard, M; Turpin, F1
Merino Moreno, J; Núñez Olarte, JM; Ortega Núñez, A; Pastor Gómez-Cornejo, L; Picó Sambucety, JM1
Kufe, DW; Robbins, G; Spriggs, DR1
Adam, T; Heidemann, E; Kloeter, I; Schabet, M; Wiethölter, H1
Blumenschein, GR; Buzdar, AU; Feldman, LD1
Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL1
Duttera, MJ; Geelhoed, GW; Graff, KS; Henderson, ES1
Carter, SK1
Hall, TC1
Cohen, SM; Greenspan, EM; Weiner, MJ1
Hobson, RW; Kingry, RL; Muir, RW1
Frei, E1
Goldie, JH; Price, LA1
Rall, DP1
Brodovsky, HS; Burke, PJ; Colsky, J; Edmonson, JH; Hall, TC; Owens, AH; Schilling, A; Shnider, BI; Wallace, HJ1

Reviews

8 review(s) available for cytarabine and Breast Cancer

ArticleYear
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    British journal of haematology, 2020, Volume: 190, Issue:3

    Topics: Aged; Allografts; Anemia, Refractory, with Excess of Blasts; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials, Phase III as Topic; Cytarabine; Daunorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm, Residual; Neoplasms, Radiation-Induced; Oncogene Proteins, Fusion; Peripheral Blood Stem Cell Transplantation; Point Mutation; Protein Kinase Inhibitors; Pyrazines; Remission Induction; Salvage Therapy; Staurosporine; Sulfonamides

2020
Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case.
    Annals of hematology, 2014, Volume: 93, Issue:12

    Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Postoperative Complications; Remission Induction; Vincristine

2014
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous

2003
Rationale for adjuvant chemotherapy.
    Cancer, 1977, Volume: 39, Issue:6 Suppl

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Floxuridine; Fluorouracil; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental

1977
Leptomeningeal carcinomatosis: a report of 3 cases and review of the literature.
    European neurology, 1992, Volume: 32, Issue:2

    Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Small Cell; Cytarabine; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Myelography; Prednisone; Vincristine

1992
Idarubicin: an anthracycline antineoplastic agent.
    Clinical pharmacy, 1992, Volume: 11, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992
An overview of the status of the nitrosoureas in other tumors.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine

1973
Predictive tests in cancer. Tuesday 9 April 1974.
    British journal of cancer, 1974, Volume: 30, Issue:2

    Topics: Age Factors; Breast Neoplasms; Cell Movement; Clinical Enzyme Tests; Colonic Neoplasms; Cytarabine; Diagnosis, Differential; Doxorubicin; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Fluorouracil; Humans; Kinetics; Leukemia; Mercaptopurine; Methods; Methotrexate; Models, Chemical; Neoplasms; Prognosis; Sarcoma; Testosterone; Thioguanine

1974

Trials

23 trial(s) available for cytarabine and Breast Cancer

ArticleYear
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
    Neuro-oncology, 2020, 04-15, Volume: 22, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Humans; Injections, Spinal; Meningeal Carcinomatosis; Quality of Life

2020
Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Clinical breast cancer, 2019, Volume: 19, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Spinal; Liposomes; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Progression-Free Survival; Survival Rate

2019
Clinical study of adjuvant capecitabine monotherapy in Chinese elderly patients (aged 55-70) with stage IIa breast cancer.
    Onkologie, 2010, Volume: 33, Issue:8-9

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; China; Cyclophosphamide; Cytarabine; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Treatment Outcome

2010
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Apr-15, Volume: 18, Issue:8

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2

2012
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
    Journal of neuro-oncology, 2002, Volume: 57, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Middle Aged; Survival Analysis

2002
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Menopause; Menopause, Premature; Menstrual Cycle; Middle Aged; Ovary; Premenopause; Prospective Studies

2006
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.
    European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Treatment Outcome

2007
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
    Cancer, 1981, Aug-01, Volume: 48, Issue:3

    Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Humans; Lomustine; Probability; Streptozocin; Tilorone; Triazines

1981
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Nausea; Random Allocation; Thrombocytopenia; Vincristine; Vomiting

1984
Southeastern Cancer Study Group: breast cancer studies 1972-1982.
    International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Time Factors; United States; Vincristine

1983
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
    Annals of the New York Academy of Sciences, 1993, Nov-30, Volume: 698

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Diethylstilbestrol; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasm Staging

1993
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.
    Anti-cancer drugs, 1996, Volume: 7, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Prednisolone; Prognosis; Tumor Cells, Cultured; Vincristine

1996
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Rate; Survivors

1999
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer.
    Breast cancer research and treatment, 1999, Volume: 58, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Electrocardiography; Epirubicin; Female; Fluorouracil; Humans; Karnofsky Performance Status; Middle Aged; Mitoxantrone; Prospective Studies; Spain; Survival Analysis; Treatment Outcome

1999
Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics: evidence for non-dosimetric factors.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2000, Volume: 57, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chi-Square Distribution; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Radiation; Epirubicin; Female; Fluorouracil; Humans; Incidence; Logistic Models; Lymph Nodes; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Pulmonary Fibrosis; Radiation Dosage; Radiation Tolerance; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Risk Factors; Statistics, Nonparametric; Thorax

2000
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    British journal of cancer, 2001, Volume: 84, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arachnoiditis; Breast Neoplasms; Cohort Studies; Cytarabine; Delayed-Action Preparations; Female; Headache; Humans; Injections, Spinal; Meningeal Neoplasms; Middle Aged; Nausea; Survival Analysis; Treatment Outcome; Treatment Refusal; Vomiting

2001
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-15, Volume: 19, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Analysis

2001
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Hematopoiesis; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Risk Factors

2001
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial co
    European journal of cancer, 1978, Volume: 14, Issue:2

    Topics: Ancitabine; Breast Neoplasms; Cytarabine; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hematologic Diseases; Humans; Lung Neoplasms; Neoplasms

1978
Cyclocytidine in breast cancer.
    Cancer treatment reports, 1978, Volume: 62, Issue:3

    Topics: Ancitabine; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Humans

1978
[Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drainage; Female; Humans; Immunotherapy, Adoptive; Lymphatic Metastasis; Lymphocytes, Tumor-Infiltrating; Middle Aged; Mitomycin; Multivariate Analysis; Picibanil; Pleural Effusion; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate

1992
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.
    Cancer, 1991, Oct-15, Volume: 68, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Prospective Studies; Survival Rate

1991
Combination intraventricular chemotherapy for meningeal neoplasia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Methotrexate; Thiotepa; Urinary Bladder Neoplasms

1986

Other Studies

101 other study(ies) available for cytarabine and Breast Cancer

ArticleYear
Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT).
    Bioorganic & medicinal chemistry, 2011, Nov-01, Volume: 19, Issue:21

    Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Mouth Neoplasms; Organophosphonates; Prodrugs; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Zidovudine

2011
Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
    International journal of biological macromolecules, 2022, Feb-28, Volume: 199

    Topics: Breast Neoplasms; Cell Survival; Chitosan; Cytarabine; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; MCF-7 Cells; Nanoparticles

2022
Clinical characteristics and management of primary granulocytic sarcoma of the breast: A case report.
    Medicine, 2019, Volume: 98, Issue:35

    Topics: Adult; Breast Neoplasms; Cytarabine; Diagnosis, Differential; Female; Homoharringtonine; Humans; Induction Chemotherapy; Mastectomy, Modified Radical; Sarcoma, Myeloid; Sentinel Lymph Node Biopsy; Treatment Outcome

2019
Synthesis and cytotoxic evaluation of apioarabinofuranosyl pyrimidines.
    Drug development research, 2020, Volume: 81, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cytarabine; Female; Humans; MCF-7 Cells; Ovarian Neoplasms; Pyrimidines; Structure-Activity Relationship

2020
To add IT chemotherapy, or not to add, that is the question.
    Neuro-oncology, 2020, 04-15, Volume: 22, Issue:4

    Topics: Breast Neoplasms; Cytarabine; Drug Therapy, Combination; Humans

2020
Proteome activity landscapes of tumor cell lines determine drug responses.
    Nature communications, 2020, 07-20, Volume: 11, Issue:1

    Topics: Adenylate Kinase; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Computational Biology; Computer Simulation; Cytarabine; Drug Development; Genomics; Humans; Leukemia, Myeloid, Acute; Neoplasms; Proteome; Proteomics; Raloxifene Hydrochloride; Receptors, Progesterone; Signal Transduction

2020
DEPOSEIN: Take with a grain of salt.
    Neuro-oncology, 2020, 11-26, Volume: 22, Issue:11

    Topics: Breast Neoplasms; Cytarabine; Humans

2020
DEPOSEIN-how meaningful was the benefit from intrathecal chemotherapy?
    Neuro-oncology, 2020, 11-26, Volume: 22, Issue:11

    Topics: Breast Neoplasms; Cytarabine; Humans; Meningeal Neoplasms

2020
Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.
    Scientific reports, 2017, 08-21, Volume: 7, Issue:1

    Topics: Antimetabolites, Antineoplastic; Biological Transport; Breast Neoplasms; Cyclodextrins; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Models, Theoretical; Phosphorylation; Tumor Cells, Cultured

2017
[Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Annales de biologie clinique, 2018, 10-01, Volume: 76, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Artifacts; Breast Neoplasms; Cerebrospinal Fluid; Cytarabine; Female; Humans; Injections, Spinal; Leukocytes; Liposomes; Meningeal Neoplasms

2018
A unique breast involvement detected by MRI-DWIBS in T cell acute lymphoblastic leukemia.
    The breast journal, 2019, Volume: 25, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Examination; Breast Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Doxorubicin; Drug Monitoring; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vincristine; Whole Body Imaging

2019
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
    Journal of neuro-oncology, 2013, Volume: 113, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; Liposomes; Meningeal Carcinomatosis; Middle Aged; Proportional Hazards Models; Retrospective Studies

2013
Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
    Breast cancer research and treatment, 2013, Volume: 141, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Eukaryotic Initiation Factor-4E; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Proteins; Paraffin Embedding; Phenotype; Prognosis; Protein Biosynthesis; Tissue Array Analysis; Treatment Outcome; Triple Negative Breast Neoplasms

2013
An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
    International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chromatin; Chromosome Aberrations; Chromosomes; Core Binding Factor Alpha 2 Subunit; Cytarabine; DNA; Enhancer Elements, Genetic; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Exome; Gene Expression Regulation, Leukemic; HeLa Cells; Hematologic Neoplasms; Humans; K562 Cells; Leukemia, Myeloid, Acute; Mutation; Polycomb Repressive Complex 2; Promoter Regions, Genetic; RNA, Long Noncoding; Translocation, Genetic

2014
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
    Journal of neuro-oncology, 2014, Volume: 119, Issue:2

    Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Disease-Free Survival; Feasibility Studies; Humans; Injections, Spinal; Kaplan-Meier Estimate; Karnofsky Performance Status; Liposomes; Lung Neoplasms; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome

2014
Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions.
    Statistics in medicine, 2014, Nov-20, Volume: 33, Issue:26

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Computer Simulation; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Life Tables; Longitudinal Studies; Methotrexate; Models, Statistical; Survival Analysis

2014
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Clinical breast cancer, 2015, Volume: 15, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Drug Administration Routes; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Methotrexate; Middle Aged; Prospective Studies

2015
Myeloid sarcoma of the breast in an aleukemic patient: a rare entity in an uncommon location.
    The Malaysian journal of pathology, 2015, Volume: 37, Issue:1

    Topics: Adult; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Cytarabine; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Immunohistochemistry; Mammography; Mastectomy; Predictive Value of Tests; Sarcoma, Myeloid; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Mammary; Unnecessary Procedures

2015
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
    Journal of neuro-oncology, 2015, Volume: 124, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain; Breast Neoplasms; Catheters, Indwelling; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Prospective Studies; Spinal Cord

2015
The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphocyte Count; Lymphocytes; MCF-7 Cells; Middle Aged; Monocytes; Prognosis; Taxoids

2016
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
    Annals of hematology, 2016, Volume: 95, Issue:11

    Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Lymphoma, B-Cell; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Salvage Therapy; Urinary Bladder Neoplasms; Vincristine

2016
Surgical treatment of solitary sternal metastasis from breast cancer Case report.
    Annali italiani di chirurgia, 2016, May-25, Volume: 87

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fractures, Spontaneous; Humans; Middle Aged; Myocutaneous Flap; Pleura; Sternum

2016
Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
    Journal of neurology, 2008, Volume: 255, Issue:11

    Topics: Antimetabolites, Antineoplastic; Brain; Breast Neoplasms; Carcinoma; Cytarabine; Female; Humans; Liposomes; Meningeal Neoplasms; Middle Aged; Radiotherapy, Adjuvant

2008
Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:10

    Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Drug Carriers; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Humans; Mice; Nanogels; Nucleosides; Polyethylene Glycols; Polyethyleneimine; Polymers; Polyphosphates

2008
[A case of stage IV breast cancer in which a long-term no change state (NC) was attained by a combination of S-1 and TAM following AC-T as a primary systemic therapy (PST)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Combinations; Female; Humans; Mitoxantrone; Neoplasm Staging; Oxonic Acid; Paclitaxel; Tegafur; Time Factors; Tomography, X-Ray Computed; Topotecan

2008
Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:3

    Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Cytarabine; Female; Humans; Injections, Spinal; Liposomes; Meningeal Carcinomatosis; Methotrexate; Middle Aged; Treatment Outcome

2009
Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.
    PharmacoEconomics, 2009, Volume: 27, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Breast Neoplasms; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Developing Countries; Economics, Pharmaceutical; Epirubicin; Female; Fluorouracil; Health Care Costs; Humans; Information Systems; Insurance Claim Reporting; Methotrexate; Models, Economic; National Health Programs; Policy Making; Taiwan

2009
Mees lines and Beau lines after chemotherapy.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Feb-23, Volume: 182, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; Docetaxel; Female; Humans; Leukemia, Myeloid, Acute; Nail Diseases; Taxoids

2010
Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Anticancer research, 2009, Volume: 29, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dacarbazine; Feasibility Studies; Female; Humans; Injections, Spinal; Liposomes; Meningeal Neoplasms; Temozolomide

2009
Optimal chemotherapy for high-risk early-stage breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome

2010
Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer.
    Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Menstruation; Middle Aged; Premenopause; Tamoxifen

2011
Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
    Breast (Edinburgh, Scotland), 2011, Volume: 20, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Liver Neoplasms; Meningeal Carcinomatosis; Methotrexate; Neoplasm Metastasis; Receptor, ErbB-2; Trastuzumab; Treatment Outcome

2011
Case of the season: Large B-cell lymphoma involving both breasts.
    Seminars in roentgenology, 2011, Volume: 46, Issue:4

    Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary

2011
Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.
    Applied biochemistry and biotechnology, 2012, Volume: 166, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Complement C3a; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Proteomics; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2012
Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
    Stem cell research, 2012, Volume: 8, Issue:2

    Topics: Adipose Tissue; Apoptosis; Azacitidine; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cytarabine; Cytosine Deaminase; Drug Screening Assays, Antitumor; Female; Fluorouracil; Genetic Engineering; Green Fluorescent Proteins; Humans; Mesenchymal Stem Cells; Recombinant Fusion Proteins; Retroviridae; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transduction, Genetic; Transgenes

2012
[Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Delivery, Obstetric; Epirubicin; Female; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Mastectomy, Segmental; Pregnancy; Tamoxifen; Twins

2003
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-15, Volume: 21, Issue:16

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Middle Aged; Neoplasms, Multiple Primary; Risk

2003
Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside.
    American journal of hematology, 2004, Volume: 76, Issue:3

    Topics: Adult; Breast Neoplasms; Cytarabine; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Uveitis, Anterior

2004
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.
    Neurology, 2004, Jul-13, Volume: 63, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Breast Neoplasms; Clone Cells; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Parietal Lobe; Remission Induction; Sequence Alignment; Sequence Homology, Nucleic Acid; Supratentorial Neoplasms; Temporal Lobe

2004
Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.
    The Journal of biological chemistry, 2004, Dec-24, Volume: 279, Issue:52

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cisplatin; Colonic Neoplasms; Cytarabine; DNA; DNA Adducts; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Inhibitors; Female; Humans; Models, Molecular; Ovarian Neoplasms; Platinum Compounds; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured

2004
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
    No shinkei geka. Neurological surgery, 2005, Volume: 33, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pulse Therapy, Drug; Radiotherapy, Adjuvant; Remission Induction; Vincristine

2005
A Case of Burkitt's Lymphoma Involving Both Breasts.
    Breast cancer (Tokyo, Japan), 2005, Volume: 12, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine

2005
[Response rates following neoadjuvant chemotherapy and breast preserving treatment in patients with locally advanced breast cancer].
    Magyar sebeszet, 2005, Volume: 58, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Docetaxel; Epirubicin; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Taxoids; Treatment Outcome

2005
[Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Lobular; Cerebrospinal Fluid; Cytarabine; Docetaxel; Drug Administration Schedule; Female; Humans; Injections, Spinal; Meningeal Neoplasms; Meningitis; Methotrexate; Quality of Life; Taxoids

2005
Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:3

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Molecular Structure

2006
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Differentiation; research in biological diversity, 2006, Volume: 74, Issue:9-10

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Caspase 7; Cell Cycle; Cell Proliferation; Cyclin D1; Cytarabine; Dimerization; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Receptor, ErbB-2; Tumor Cells, Cultured

2006
Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity.
    Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2007, Volume: 33, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Arousal; Autonomic Nervous System; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Individuality; Methotrexate; Middle Aged; Perception; Radiotherapy, Adjuvant; Sick Role; Statistics as Topic; Vomiting, Anticipatory

2007
t(8;16) AML developed subsequent to breast cancer therapy.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles

2006
Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A.
    The New England journal of medicine, 1981, Nov-12, Volume: 305, Issue:20

    Topics: Antigen-Antibody Complex; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cytarabine; Female; Follow-Up Studies; Hemoperfusion; Humans; Middle Aged; Plasma; Staphylococcal Protein A

1981
The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Drug Resistance; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Neoplasms

1984
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms

1995
Combination intraventricular therapy with thiotepa and cytarabine in meningeal carcinomatosis due to breast cancer: in vitro evidence for supra-additive cytotoxicity.
    Anti-cancer drugs, 1995, Volume: 6, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Synergism; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Middle Aged; Salvage Therapy; Thiotepa; Tumor Cells, Cultured

1995
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Cancer research, 1996, May-15, Volume: 56, Issue:10

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biotransformation; Breast Neoplasms; Carcinoma, Small Cell; Cladribine; Colonic Neoplasms; Cytarabine; Deoxycytidine Kinase; DNA, Complementary; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genetic Vectors; Humans; Lung Neoplasms; Moloney murine leukemia virus; Phosphorylation; Recombinant Fusion Proteins; Tumor Cells, Cultured; Vidarabine

1996
Deficient DNA repair capacity, a predisposing factor in breast cancer.
    British journal of cancer, 1996, Volume: 74, Issue:1

    Topics: Animals; Breast Neoplasms; CHO Cells; Chromatids; Cricetinae; Cytarabine; DNA Damage; DNA Repair; DNA, Neoplasm; Female; Humans; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Risk Factors; Transfection; Ultraviolet Rays; X-Rays; Xeroderma Pigmentosum

1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models.
    Investigational new drugs, 1996, Volume: 14, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Molecular Structure; Pancreatic Neoplasms; Transplantation, Heterologous; Treatment Outcome

1996
Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells.
    International journal of cancer, 1997, Jan-17, Volume: 70, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Caffeine; Cell Cycle; Cisplatin; Cytarabine; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Doxorubicin; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent; Paclitaxel; Tumor Cells, Cultured

1997
Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding.
    Oncogene, 1997, Mar-13, Volume: 14, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cysteine Endopeptidases; Cytarabine; DNA-Binding Proteins; E2F Transcription Factors; Etoposide; fas Receptor; Female; HL-60 Cells; Humans; Peptide Fragments; Phosphorylation; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors

1997
Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
    Leukemia, 1997, Volume: 11, Issue:5

    Topics: Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cytarabine; Cytotoxicity, Immunologic; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cells; HL-60 Cells; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia; Lung Neoplasms; Lymphocyte Activation; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous; Tumor Cells, Cultured

1997
A durable response to cytarabine in advanced breast cancer.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1997, Volume: 9, Issue:3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Lobular; Combined Modality Therapy; Cytarabine; Female; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Medication Errors; Middle Aged; Radiotherapy Dosage; Superior Vena Cava Syndrome

1997
1-beta-D-Arabinofuranosylcytosine-5'-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C.
    Journal of lipid research, 1998, Volume: 39, Issue:1

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Calcium; Cell Division; Cell Line; Cytarabine; Female; Humans; Leukemia P388; Mice; Molecular Structure; Phospholipid Ethers; Structure-Activity Relationship; Tumor Cells, Cultured

1998
Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design

1998
Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk.
    Biochemical and biophysical research communications, 1999, Apr-13, Volume: 257, Issue:2

    Topics: Breast; Breast Neoplasms; Cells, Cultured; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Hydroxyurea; Micronucleus Tests; Milk, Human; Mutagenicity Tests; Mutagens; Pilot Projects; Ribosomal Protein S9; Ribosomal Proteins; Salmonella typhimurium; Time Factors

1999
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    International journal of cancer, 1999, Jul-19, Volume: 82, Issue:2

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformation; Breast Neoplasms; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Deoxycytidine Kinase; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; KB Cells; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Mitomycin; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Nude; Specific Pathogen-Free Organisms; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine

1999
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting

1999
Risk of menopause during the first year after breast cancer diagnosis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fluorouracil; Humans; Mastectomy; Menopause, Premature; Methotrexate; Middle Aged; Multivariate Analysis; Premenopause; Probability; Risk Factors; Tamoxifen

1999
Epirubicin regimen cuts risk of death in premenopausal women with early breast cancer.
    Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Female; Humans; Premenopause; Survival Rate

1999
Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:4

    Topics: Antigens, Polyomavirus Transforming; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cell Division; Cytarabine; DNA Polymerase I; DNA Polymerase III; DNA Replication; DNA, Neoplasm; Humans; Replicon; Tumor Cells, Cultured

2000
Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:4

    Topics: Antigens, Polyomavirus Transforming; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cloning, Molecular; Cytarabine; Deoxycytidine; DNA Polymerase I; DNA Polymerase III; DNA, Neoplasm; Gemcitabine; Humans; Replicon; Tumor Cells, Cultured

2000
Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.
    International journal of oncology, 2000, Volume: 17, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intercellular Adhesion Molecule-1; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Recombinant Proteins; Solubility

2000
Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation.
    International journal of oncology, 2000, Volume: 17, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; CD18 Antigens; Combined Modality Therapy; Cytarabine; Etoposide; Female; Filgrastim; Gene Expression Regulation, Leukemic; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Macrophage-1 Antigen; Male; Melphalan; Middle Aged; Neoplasm Proteins; Neutropenia; Recombinant Proteins; Remission Induction

2000
Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Carmustine; Cell Lineage; Combined Modality Therapy; Cytarabine; Disease Susceptibility; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Melphalan; Middle Aged; Podophyllotoxin; Sweden; Transplantation Conditioning; Transplantation, Autologous

2000
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Cognition; Cytarabine; Female; Humans; Meningeal Neoplasms; Middle Aged; Survival Analysis; Treatment Outcome

2000
An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer.
    Breast cancer (Tokyo, Japan), 2002, Volume: 9, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Logistic Models; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Survival Rate; Treatment Outcome

2002
Burkitt's lymphoma presenting during lactation.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1976, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Autopsy; Breast Diseases; Breast Neoplasms; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Female; Humans; Lactation; Male; Methotrexate; Pregnancy

1976
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Cytarabine; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Male; Malignant Carcinoid Syndrome; Middle Aged; Neoplasms

1979
Blindness as initial manifestation of meningeal carcinomatosis in breast cancer.
    Cancer, 1979, Volume: 44, Issue:2

    Topics: Blindness; Breast Neoplasms; Cytarabine; Female; Humans; Meningeal Neoplasms; Middle Aged

1979
Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients.
    Gan, 1979, Volume: 70, Issue:4

    Topics: Adrenalectomy; Adult; Aged; Breast Neoplasms; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycins; Receptors, Estrogen

1979
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo.
    International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:9

    Topics: Breast Neoplasms; Cell Line; Cell Survival; Cytarabine; Drug Therapy, Combination; Estradiol; Female; Humans; Methotrexate; Neoplasms, Hormone-Dependent; Tamoxifen

1979
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
    Cancer research, 1978, Volume: 38, Issue:8

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Humans; Kinetics; Neoplasms, Experimental; Receptors, Estrogen

1978
Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man.
    Journal of surgical oncology, 1978, Volume: 10, Issue:5

    Topics: Adult; Aged; Bone Marrow; Breast Neoplasms; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Melena; Middle Aged; Mitomycins; Neoplasm Metastasis; Remission, Spontaneous; Stomach Neoplasms

1978
Nuclear DNA polymerases of human carcinomas.
    Cancer research, 1977, Volume: 37, Issue:3

    Topics: Animals; Breast Neoplasms; Cecal Neoplasms; Cecum; Cell Nucleus; Cytarabine; DNA-Directed DNA Polymerase; DNA, Neoplasm; Humans; Isoenzymes; Liver; Liver Regeneration; Lung; Lung Neoplasms; Neoplasms; Novobiocin; Nucleic Acid Synthesis Inhibitors; Rats

1977
Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approach.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Humans; Injections, Intravenous; Methotrexate; Research Design; Vincristine

1976
Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
    Cancer research, 1990, Feb-01, Volume: 50, Issue:3

    Topics: Basement Membrane; Breast Neoplasms; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Magnetic Resonance Spectroscopy; Nucleotidyltransferases; Phosphatidylcholines; Phosphatidylethanolamines; Phosphoric Diester Hydrolases; Tumor Cells, Cultured

1990
Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis.
    Cancer, 1990, Feb-01, Volume: 65, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Breast Neoplasms; Coma; Cytarabine; Demyelinating Diseases; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Methotrexate

1990
Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk-related glycoproteins in MCF-7 breast carcinoma cells.
    Journal of cellular physiology, 1986, Volume: 126, Issue:1

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Cell Differentiation; Cell Line; Cross Reactions; Cytarabine; Female; Glycoproteins; Humans; Methionine; Milk Proteins; Molecular Weight; Neuraminidase; Protein Biosynthesis; RNA; Tetradecanoylphorbol Acetate

1986
Accidental overdose of mitoxantrone in three patients.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Cytarabine; Drug Overdose; Drug Tolerance; Female; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone

1989
[Continuous venous infusion in cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:4

    Topics: Bleomycin; Bone Marrow; Breast Neoplasms; Cytarabine; Doxorubicin; Drug Administration Schedule; Fluorouracil; Heart; Humans; Infusions, Parenteral; Lung Neoplasms; Neoplasms

1985
Mitoxantrone.
    The Medical letter on drugs and therapeutics, 1988, Jul-01, Volume: 30, Issue:769

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; DNA; Drug Administration Schedule; Humans; Leukemia; Mitoxantrone

1988
[An unusual way of manifesting acute granulocytic leukemia: granulocytic sarcoma of the breast. Apropos of a case with trisomy 22].
    Nouvelle revue francaise d'hematologie, 1986, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, 21-22 and Y; Cytarabine; Daunorubicin; Female; Granulocytes; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms, Multiple Primary; Trisomy

1986
[Granulocytic sarcoma (chloroma) with bladder and breast localizations preceding acute myeloblastic leukemia].
    Revista clinica espanola, 1987, Volume: 180, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Combinations; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Time Factors; Urinary Bladder Neoplasms; Vincristine

1987
Effects of cis-diamminedichloroplatinum on DNA incorporation and cytotoxicity of 1-beta-D-arabinofuranosylcytosine.
    Biochemical pharmacology, 1986, Dec-01, Volume: 35, Issue:23

    Topics: Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Cytarabine; DNA; DNA Damage; DNA Repair; Drug Interactions; Humans

1986
Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer.
    European neurology, 1986, Volume: 25, Issue:6

    Topics: Adult; Brain; Breast Neoplasms; Carcinoma; Cerebrospinal Fluid; Cytarabine; Female; Humans; Meningeal Neoplasms; Methotrexate; Middle Aged; Tomography, X-Ray Computed

1986
High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer.
    Oncology, 1985, Volume: 42, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Cytarabine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypotension; Middle Aged

1985
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
    Oncology, 1974, Volume: 29, Issue:3

    Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting

1974
Acute leukemia presenting as a breast mass.
    JAMA, 1973, Mar-26, Volume: 223, Issue:13

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Biopsy, Needle; Breast Neoplasms; Child; Cytarabine; Daunorubicin; Diagnosis, Differential; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Menarche; Mercaptopurine; Methotrexate; Prednisolone; Sulfates; Vincristine

1973
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting

1972
Cecal necrosis and perforation with systemic chemotherapy.
    The American surgeon, 1973, Volume: 39, Issue:3

    Topics: Adult; Asparaginase; Breast Neoplasms; Cecal Diseases; Child; Cytarabine; Daunorubicin; Female; Fluorouracil; Humans; Intestinal Perforation; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Necrosis; Prednisone; Thioguanine; Vincristine

1973
Status and perspectives in chemotherapy of Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Evaluation Studies as Topic; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mitosis; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1973
Multiple drug therapy for disseminated malignant tumours.
    British medical journal, 1971, Nov-06, Volume: 4, Issue:5783

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Female; Fluorouracil; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Urinary Bladder Neoplasms; Vincristine

1971
New approaches in administration of anticancer drugs.
    Cancer research, 1969, Volume: 29, Issue:12

    Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Mercaptopurine; Methotrexate; Neoplasms; Prognosis; Time Factors

1969
A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
    Cancer research, 1970, Volume: 30, Issue:5

    Topics: Adenocarcinoma; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cytarabine; Female; Hematopoiesis; Humans; Leiomyosarcoma; Leukocyte Count; Liver; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Sarcoma; Ureteral Neoplasms; Urethral Neoplasms

1970